TIM S.A. Sponsored ADR TIMB 深 滬
已收盤 02-06 16:00:00 美东时间
24.46
+0.240
+0.99%
華盛通- 最 高24.555
- 今 開24.45
- 成交量 26.33万股
- 最 低 24.24
- 昨 收 24.22
- 總市值 117.65亿
- 52周最高 24.555
- 市盈率 靜 20.24
- 換手率 0.05%
- 52周最低 11.7067
- 委 比 60.00%
- 總股本 4.81亿
- 歷史最高 24.555
- 量 比 0.75
- 振 幅 1.30%
- 歷史最低 5.3666
- 每 手 1
- 風險率 3.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TIM SA Confirms Ongoing Talks to Acquire Stake in I-Systems
TIM SA Confirms Ongoing Talks to Acquire Stake in I-Systems TIM S.A. is engaged in ongoing, non-binding negotiations regarding the potential acquisition of a stake in I-Systems. The company clarified that details reported in the media, including transaction amounts and other specifics, have not been
02-03 20:15
TIM S.A. Completes Acquisition of V8.Tech to Bolster Tech Capabilities
An announcement from TIM ( ($TIMB) ) is now available. On January 30, 2026, TIM...
01-31 06:20
TIM SA Signs Strategic Infrastructure Agreement with American Tower
TIM SA Signs Strategic Infrastructure Agreement with American Tower TIM S.A. has announced the approval and execution of a new strategic agreement with American Tower do Brasil - Cessão de Infraestruturas S.A. The agreement covers approximately 9,000 towers, representing about 30% of TIM's infrastru
01-22 08:17
TIM S.A. Raises Per-Share Dividend After Treasury Share Adjustment
TIM ( ($TIMB) ) has issued an update. On December 26, 2025, TIM S.A. announced ...
2025-12-29 19:57
11 Communication Services Stocks Moving In Wednesday's Pre-Market Session
Gainers Surgepays (NASDAQ:SURG) stock rose 4.3% to $1.93 during Wednesday's pr...
2025-12-24 20:05
TIM S.A. Expands B2B Strategy with Acquisition of V8.Tech
TIM ( ($TIMB) ) has shared an update. On November 27, 2025, TIM S.A. announced ...
2025-11-28 19:48
美股盘后 | 思科涨7.49%，Revolution Medicines涨3.30%
思科涨7.49%；Revolution Medicines涨3.30%；Royalty pharma plc涨2.85%
2025-11-13 07:11
TIM S.A. Reinforces Regulatory Compliance with SEC Filing
The latest update is out from TIM ( ($TIMB) ). On November 10, 2025, TIM S.A. s...
2025-11-11 06:27
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
